“Do not impact fertility.” That was the headline assurance in a February 2021 joint statement from the American College of Obstetricians and Gynecologists and two other reproductive medicine organizations. Yet, its text acknowledged that fertility had not been specifically studied in Pfizer’s COVID-19 vaccine clinical trials. It described loss of fertility as scientifically unlikely. The statement is reproduced in ASRM’s February 2021 guidance.
A conclusion and an expectation are different things. Patients deserved to hear the difference. As a surgeon, I believe a credible safety concern deserves explanation before causation is settled. Informed consent requires discussing uncertainty while patients still have a decision to make.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.